1. Jakesz R Comparison of pre- vs. postoperative chemotherapy in breast cancer patients: Four-year results of Austrian breast & colorectal cancer study group (ABCSG) trial 7 American Society of Clinical Oncology. Annual Meeting 2001 Abstract 125
2. Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre;Mauriac;Annals of Oncology,1991
3. Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS);Mauriac;Annals of Oncology,1999
4. Eiermann W Sabadell D Baselga J Vazquez V Guillem Porta V European cooperative trial in operable breast cancer (ECTO): No increased risk of local breast tumor recurrence (LBR) as first and only event after primary systemic therapy (PST) American Society of Clinical Oncology 2003 Abstract 37
5. European cooperative trial in operable breast cancer (ECTO): Improved freedom from progression (FFP) from adding paclitaxel (T) to doxorubicin (A) followed by cyclophosphamide methotrexate and fluorouracil (CMF);Gianni;Journal of Clinical Oncology, ASCO Annual Meeting Proceedings,2005